(2026). Multiple omics analyses and experiments validation identify PRDX3 as a biomarker of prognosis and antioncogene in kidney clear cell carcinoma. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Multiple Omics Analyses and Experiments Validation Identify PRDX3 as a Biomarker of Prognosis and Antioncogene in Kidney Clear Cell Carcinoma."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Multiple Omics Analyses and Experiments Validation Identify PRDX3 as a Biomarker of Prognosis and Antioncogene in Kidney Clear Cell Carcinoma."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.